H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 9.1% of adults in Raleigh have diagnosed diabetes — 2.9 points below the U.S. 12% figure. Census population 474,069. North Carolina Medicare wound biologics: Palmetto GBA (JM). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Raleigh clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Raleigh storefront.
Joint Preservation Therapy Solutions in Raleigh, NC for clinics & physicians. Joint preservation therapy h… Compliance support & pricing — contact Hawk Medical.
CDC PLACES (2023, crude) estimates 9.1% of adults in Raleigh have diagnosed diabetes — 2.9 points below the U.S. 12% figure. Census city-proper population is 474,069. If you are adding joint preservation therapy, start with that epidemiology and with Palmetto GBA (JM) — not with a “near me” clinic listing. Hawk Medical ships nationwide; Joe Bradley’s own practice uses the same product classes.
National Joint Preservation Therapy Solutions notes (how the product actually works)JM reviewers still want serial wound measurements and conservative-care history before CTPs, whether diabetes in Raleigh is 9.1% or not. PLACES is planning data. The LCD is the claim.
Vendor consolidation is boring on purpose: one account, IFUs filed, JM articles mapped. 9.7% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. Pricing scripts have to match that mix. We will help write them. We will not book your patients.
CDC PLACES (2023, crude prevalence) estimates 9.1% of adults — 2.9 points below the U.S. 12% figure. Obesity is 30.9%; arthritis is 19.8%. That is place-level BRFSS modeling, not a clinic census and not a Raleigh trial.
It is the Census city-proper count — useful as scale for a city of 250k–500k. It is not a count of orthopedic groups, wound centers, or competitors. Underwrite the program against your referral sources, not against the skyline.
The allograft is used to perform the same basic function in the recipient as in the donor (FDA 361). Using umbilical or amniotic tissue as a marketed “stem cell cure” for unrelated conditions is outside that lane and is a North Carolina compliance risk.
North Carolina includes Diabetes Belt counties in CDC’s published geography. That supports a higher index of suspicion for DFU and chronic-wound volume. It is not a license to skip offloading, vascular assessment, or JM documentation.
If you operate in North Carolina and another MAC state, say it on the first call. JM will not port 1:1. We would rather split utilization than watch a sister clinic copy Raleigh tickets into the wrong jurisdiction.
Contact us to learn how Hawk Medical supports practices in Raleigh, NC.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Raleigh is JM geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Raleigh — 2.9 points below the U.S. 12% figure. Planning input, not an outcomes claim.
North Carolina Part B wound biologics follow this contractor (siblings: SC, VA, WV). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Raleigh. Useful for joint-program math; still needs a diagnosis and privileging.
No Raleigh storefront. Joe Bradley is an active practice owner. joint preservation therapy stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.